Who
Michael J. Brooks
President
Company insider
Files Form 4 as: President, Edesa Biotech.
In numbers
- Trades disclosed
- 39
- Buys
- 11
- Sells
- 0
- Bought
- $88K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 7 Jun 2019
- Last trade
- 27 May 2026
- Last filed
- 29 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 27 May 2026filed 29 May 2026 | EDSA Edesa BiotechBiotechnology | SEC FORM 4 Code A | —64,609 at $0.00 | filing |
| 27 May 2026filed 29 May 2026 | EDSA Edesa BiotechBiotechnology | SEC FORM 4 Code A | —64,609 at $0.00 | filing |
| 26 Feb 2026filed 11 Mar 2026 | EDSA Edesa BiotechBiotechnology | SEC FORM 4 Bought | $3,1402,000 at $1.57 | filing |
| 26 Feb 2026filed 11 Mar 2026 | EDSA Edesa BiotechBiotechnology | SEC FORM 4 Bought | $3,1402,000 at $1.57 | filing |
| 29 May 2025filed 2 Jun 2025 | EDSA Edesa BiotechBiotechnology | SEC FORM 4 Code A | —207,201 at $0.00 | filing |
| 4 Aug 2023filed 4 Aug 2023 | EDSA Edesa BiotechBiotechnology | SEC FORM 4 Code A | —93,200 | filing |
| 20 Jul 2023filed 24 Jul 2023 | EDSA Edesa Biotechoption or derivative · Biotechnology | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 20 Jul 2023filed 21 Jul 2023 | EDSA Edesa Biotechoption or derivative · Biotechnology | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 2 Nov 2022filed 4 Nov 2022 | EDSA Edesa Biotechoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,119 | filing |
| 2 Nov 2022filed 4 Nov 2022 | EDSA Edesa Biotechoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,119 | filing |
| 2 Nov 2022filed 4 Nov 2022 | EDSA Edesa BiotechBiotechnology | SEC FORM 4 Code A | $4,7904,239 at $1.13 | filing |
| 29 Jun 2022filed 30 Jun 2022 | EDSA Edesa BiotechBiotechnology | SEC FORM 4 Bought | $4,4703,000 at $1.49 | filing |
| 16 Jun 2022filed 21 Jun 2022 | EDSA Edesa BiotechBiotechnology | SEC FORM 4 Bought | $4,8303,000 at $1.61 | filing |
| 25 May 2022filed 26 May 2022 | EDSA Edesa BiotechBiotechnology | SEC FORM 4 Bought | $6,0903,500 at $1.74 | filing |
| 14 Mar 2022filed 15 Mar 2022 | EDSA Edesa BiotechBiotechnology | SEC FORM 4 Bought | $3,4881,250 at $2.79 | filing |
| 10 Mar 2022filed 11 Mar 2022 | EDSA Edesa BiotechBiotechnology | SEC FORM 4 Bought | $3,2201,000 at $3.22 | filing |
| 8 Mar 2022filed 9 Mar 2022 | EDSA Edesa BiotechBiotechnology | SEC FORM 4 Bought | $3,6251,250 at $2.90 | filing |
| 28 Feb 2022filed 7 Mar 2022 | EDSA Edesa Biotechoption or derivative · Biotechnology | SEC FORM 4 Code A | —43,500 at $0.00 | filing |
| 22 Apr 2021filed 26 Apr 2021 | EDSA Edesa Biotechoption or derivative · Biotechnology | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 25 Mar 2021filed 26 Mar 2021 | EDSA Edesa BiotechBiotechnology | SEC FORM 4 Bought | $18K3,500 at $5.19 | filing |
News
Michael J. Brooks: The table of brotherhoodyellowhammernews.com · 18 Oct 2026Edesa Biotech Announces FDA IND Clearance for Phase 2 Vitiligo StudyEDSA · elliotlakestandard.ca · 15 Oct 2026Edesa Biotech (NASDAQ:EDSA) Stock Falls 16.2% – Time to Sell?EDSA · themarketsdaily.com · 13 Oct 2026
1 headline in the last 90 days name Michael J. Brooks; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.